ABVD plus radiotherapy versus EVE plus radiotherapy in unfavorable stage IA and IIA Hodgkin's lymphoma: results from an Intergruppo Italiano Linfomi randomized study. [PDF]
, 2008 BACKGROUND: In 1997, the Intergruppo Italiano Linfomi started a randomized trial to evaluate, in unfavorable stage IA and IIA Hodgkin's lymphoma (HL) patients, the efficacy and toxicity of the low toxic epirubicin, vinblastine and etoposide (EVE) regimen
Angelucci, E +14 more
core +1 more source
JEADV Clinical Practice, Volume 4, Issue 2, Page 552-555, June 2025.
Michelle Raaijmakers +5 more
wiley +1 more source
An overview of different methods to establish a murine premature ovarian failure model
Animal Models and Experimental Medicine, Volume 7, Issue 6, Page 835-852, December 2024.Ten different methods to induce murine POF models: (1) POF model induced by chemotherapy drugs, (2) radiotherapy‐induced POF model, (3) genetically induced POF model, (4) POF model induced by D‐galactose, (5) natural ovarian aging (NOA)‐induced POF model (6) physiological POF model with consecutive superovulation, (7) oophorectomy POF model, (8) POF ...
Negar Pouladvand +4 more
wiley +1 more source
Adult life after surviving lymphoma in childhood [PDF]
, 2018 Introduction: Almost all pediatric lymphomas are malignant, high-grade tumors. The combined incidence of Hodgkin's disease (HD) and non-Hodgkin lymphoma (NHL) reaches 10 to 12 new cases a year per million children under the age of 16years, representing ...
von der Weid, Nicolas
core
Plant‐Based Anticancer Compounds With a Focus on Breast Cancer
Cancer Reports, Volume 7, Issue 10, October 2024.ABSTRACT Breast cancer is a common form of cancer among women characterized by the growth of malignant cells in the breast tissue. The most common treatments for this condition include chemotherapy, surgical intervention, radiation therapy, hormone therapy, and biological therapy.
Amin Moradi Hasan‐Abad +4 more
wiley +1 more source
Hodgkin disease of thymic origin [PDF]
, 2002 J Thorac Cardiovasc Surg 2002;123:1208 ...
Calvo, María José Roca +4 more
core +3 more sources
Dynamic Rearrangement of Cell States Detected by Systematic Screening of Sequential Anticancer Treatments [PDF]
, 2017 Signaling networks are nonlinear and complex, involving a large ensemble of dynamic interaction states that fluctuate in space and time. However, therapeutic strategies, such as combination chemotherapy, rarely consider the timing of drug perturbations ...
Blicher Bjerregård, Mathias +9 more
core +3 more sources
Drug Design, Development and Therapy, 2018 Kendall Liner,1 Celeste Brown,2 Laura Y McGirt3 1Division of Dermatology, Medical College of Georgia at Augusta Health, Augusta, GA, USA; 2School of Medicine, University of North Carolina at Chapel Hill, Carolinas Medical Center, Charlotte, NC, USA ...
Liner K, Brown C, McGirt LY
doaj
CCNU, vinblastine, procarbazine and prednisone (CVPP) with extended-field radiotherapy in the treatment of early unfavorable Hodgkin's disease - A prospective study on behalf of the Gruppo Italiano per lo Studio dei Linfomi (GISL) [PDF]
, 1996 Purpose. To test the adequacy of the CVPP four-drug regimen as ancillary chemotherapy associated with extended-field radiotherapy in the treatment of early, unfavorable, clinically staged Hodgkin's disease. Patients and Methods.
Angrilli, F +11 more
core
Progress in Hodgkin lymphoma: a population-based study on patients diagnosed in Sweden from 1973-2009. [PDF]
, 2012 To access publisher's full text version of this article. Please click on the hyperlink in Additional Links field.In recent decades, attention has focused on reducing long-term, treatment-related morbidity and mortality in Hodgkin lymphoma (HL).
Bjorkholm, Magnus +7 more
core +1 more source